Oracle Under Pressure From Debt and Massive Layoffs
Oracle confronts a heavy debt burden and sweeping layoffs as it presses ahead with a three-step transformation, raisi...
Why Stock Indices Go Up And Down
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,658 articles
Lien 2026 Earnings Transcript: Key Takeaways & Analysis
This in depth review breaks down the lien 2026 earnings transcript in plain language. You’ll see what the numbers mea...
Will Stocks React U.S. Markets After Iran Action Today?
Geopolitical shocks can jolt markets, but smart prep helps. This guide breaks down what to expect, how to react, and ...
Great News: Zscaler Just Made a Bold AI Security Move
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
Famed Venture Capital Fund Says SpaceX Echoes Nvidia 2023
A famed venture capital fund draws a bold parallel between SpaceX’s post-IPO trajectory and Nvidia’s 2023 surge, fram...
Most Retirees Choose JEPI, but This 4.8% Yield Outperforms
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
Longtime Bitcoin Advocate Says MicroStrategy Could Hit $1,000
A longtime bitcoin advocate says MicroStrategy is a leveraged proxy for Bitcoin, and could trade at $1,000 per share ...
What Will Ethereum Worth by End of 2026: Market Outlook
Ethereum sits near $2,100 in May 2026 as the market weighs upgrades, staking growth and ETF demand. This story breaks...
Better ETF: Choosing VOO vs SPY in the S&P 500 Arena
Which S&P 500 ETF is the better etf for you? This guide compares VOO and SPY on costs, liquidity, and tracking, with ...
This Value-Stock Strategy Trounced the Market for Years
A disciplined value-focused approach has outpaced the S&P 500 for almost five years, signaling a leadership shift as ...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Palantir Just Beat Earnings, Yet Stock Dives Again
Palantir just beat earnings, yet its stock fell in after-hours trading as traders priced in slower growth and macro h...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status